Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Danish synthetic biology company Octarine announces successful completion of funding as it advances sustainable, nature-based dyes for the fashion industry


News provided by

Octarine Bio

Nov 08, 2023, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Octarine, a leading synthetic biology platform company developing new colours and sustainable dyeing technologies to transform the fashion and food industries, today announced the completion of its oversubscribed €4.35 million ($4.6 million) funding round to accelerate and scale its flagship products, extending its total funding received to date to over €12M. The round was led by Óskare Capital, Unconventional Ventures, and The Footprint Firm with participation from dsm-firmenich Venturing.

COPENHAGEN, Denmark, Nov. 8, 2023 /PRNewswire-PRWeb/ -- Octarine's OB-CLR™ is a response to the pressing environmental and societal issues within the textile dyeing industry. The company employs a first-in-industry precision fermentation process to develop a vibrant spectrum of sustainable nature-based dyes which can be seamlessly integrated into an organisation's existing supply chain, fuelling positive change one vibrant hue at a time.

Currently, the vast majority of textile dyes are synthetic and derived from petroleum, thus constituting a highly unsustainable and damaging production process. In addition to petroleum being a non-renewable raw material, the production of synthetic dyes requires extreme conditions – such as high temperatures – and releases toxic chemicals into the environment. The textile dyeing process is also a major environmental concern, being responsible for over 2.4% of all greenhouse gas emissions, 20% of the world's wastewater, and 35% of all chemicals released into the environment. There is also evidence indicating that many synthetic textile days are toxic, carcinogenic, and mutagenic. Octarine's microbially fermented colours provide sustainable alternatives to both the production of textile dyes, as well as the dyeing process. Octarine's colour program is focused on violacein and its derivatives, providing a highly sought-after and difficult-to-source colour spectrum, while Octarine's proprietary textile dyeing process further enables a significant reduction in environmental footprint as its colours can be dyed directly onto natural and synthetic fibres under ambient conditions without any additional chemicals or mordants.

These colours are currently undergoing rapid development in collaboration with Ginkgo Bioworks, announced earlier this year. This funding round will support Octarine Bio to scale and optimize its colours in preparation for commercialisation.

Alexandre Ouimet-Storrs, President and Co-Founder of Óskare Capital, stated that "Óskare Capital scouted and first invested in Octarine three years ago and they have made phenomenal progress since then, expanding its pipeline and validating its platform beyond initial products. The sustainable dye product line is truly ground-breaking, and we hope to see many more innovative products come to market thanks to Octarine's strong biotech platform."

"The textile industry must switch to a more aggressive decarbonization trajectory in order to reduce its contribution to greenhouse gas emissions, water pollution and, ultimately, climate change. Octarine's ground-breaking technology leads the way in transitioning the industry towards sustainable practices and away from harmful synthetic dyes. With Nethaji and Nick's expertise, execution power, and visionary leadership, we are confident they will make a lasting impact on the fashion industry, making us a proud backer of Octarine," commented Thea Messel, Founder and General Partner at Unconventional Ventures.

"We are truly excited to partner with Octarine on this next part of their journey and are keen to help accelerate success and ultimately enable the fashion industry to take a much-needed leap towards a more sustainable future. We are deeply impressed with what the team has achieved and find their scientific foundation and truly novel dyeing solution second to none," commented Jonas Ahm-Lundgren, Chief Investment Officer at The Footprint Firm.

Nethaji Gallage, CEO and co-founder of Octarine, stated that "at Octarine, we are driven by a more sustainable future where pressing environmental and social challenges are met with innovative, game-changing, and sustainable solutions. Octarine's strong synthetic biology platform has allowed us to quickly iterate from one ingredient to the next validating our platform capabilities, and today we collaborate with global industry leaders on the path to commercialization of our flagship products. We're thrilled to welcome Unconventional Ventures and The Footprint Firm on our exciting journey, and we're pleased to receive follow-on investments from existing investors and greatly appreciate their continued support in our commitment to pioneering innovative solutions that can truly transform our world."

About Octarine Bio

Octarine harnesses the science of nature to pioneer planetary solutions through exploration and innovation. Driven by a sustainable future where pressing environmental and social challenges are met with transformative solutions. Grounded in a robust scientific foundation and unrivalled expertise in cell factory engineering, precision fermentation and enzymatic enhancement, we proudly unveil world-leading synthetic biology platforms, poised to transform entire industries for the betterment of society and the planet. Utilizing our proprietary fermentation-based manufacturing platform, our flagship product is a range of environmentally responsible, nature-based dyes in commercially elusive, vibrant colours. Employing an innovative dyeing process, they can be efficiently and directly dyed on a range of natural and synthetic fabrics under ambient conditions and without the use of harmful chemicals. Notably, these vibrant dyes can also be scaled up and seamlessly integrated into our commercial partners' existing supply chains; because we believe that colours shouldn't come at an environmental cost.

For more information, visit octarinebio.com or follow us on LinkedIn and Twitter.

Media Contact

Nethaji Gallage, Octarine Bio, 45 27639353, info@octarinebio.com

SOURCE Octarine Bio

Modal title

Octarine Bio produces bio-based colours using a proprietary precision fermentation process
Octarine Bio produces bio-based colours using a proprietary precision fermentation process
Octarine Bio produces bio-based colours using a proprietary precision fermentation process

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.